Search

Author/Creator Brunetto, M.

11. Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy. (February 2019)

Authors:
Pasulo, L.; Gambato, M.; Spinetti, A.; D'Ambrosio, R.; Puoti, M.; Ciancio, A.; Di Marco, V.; Calvaruso, V.; Colombatto, P.; Brunetto, M.; Schiavini, M.; Fabris, P.; Sacchi, P.; Gulminetti, R.; Carolo, G.; Scotton, P.; Pozzan, C.; Vinci, M.; Viganò, M.; Lombardi, A.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen. (February 2020)

Authors:
Di Maio, V.C.; Aragri, M.; Masetti, C.; Paolucci, S.; Bruzzone, B.; Degasperi, E.; Barbaliscia, S.; Pollicino, T.; Minichini, C.; Calvaruso, V.; Rendina, M.; Cento, V.; Teti, E.; Micheli, V.; Allice, T.; Polilli, E.; Palitti, V. Pace; Landonio, S.; Lenci, I.; Francioso, S.
Journal:
Digestive and liver disease
Issue:
Volume 52(2020)Supplement 1
Page Start:
e2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗